Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mFOLFOX6 Plus Bevacizumab for Unresectable Stage IV Colon Cancer With Asymptomatic Primary Tumor
NCT00321828Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- Mar 2006
- Primary completion
- Nov 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colon cancer, sponsored by NSABP Foundation. Started Mar 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00321828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321828.